{"docstore/metadata": {"data/MARIO MESTAZ/Progress Note_2025-07-01_1_4_5.pdf": {"doc_hash": "13750aec692d5065ebe4cec430353eb9398e052481de54ae2f6d90bdde153cce"}, "data/MARIO MESTAZ/NEW Progress Note (1).pdf": {"doc_hash": "39be74e153f69c227da3c9b8dd93cf6a1679b8c70edeaf1ca77b821367be98d6"}, "data/MARIO MESTAZ/Manual_2025-07-01_3_1_5.pdf": {"doc_hash": "53770b1f7171389e7a80173ca691e8bf14d08f9595ad1143b6f3362f97c2b57a"}, "6c03fdee-df34-43f3-839d-e63aa9fd91c1": {"doc_hash": "712f2d9c92b516346902fc6ec031b83aa04ca7fc9fc62e161af27dd756bc7bfb", "ref_doc_id": "data/MARIO MESTAZ/Progress Note_2025-07-01_1_4_5.pdf"}, "16ebdd77-0c55-4efc-8881-048402345460": {"doc_hash": "553bce47e047bb64b1c245ab73ab0c2704168239b795aee8bcfbb482b66a7c0a", "ref_doc_id": "data/MARIO MESTAZ/Progress Note_2025-07-01_1_4_5.pdf"}, "5b04fd55-7c84-435d-993d-c276bd314b7f": {"doc_hash": "e5dd83b1c1b652bbcdf613e9282874b9106236dc2802c3a2c0c8d0443bfddadd", "ref_doc_id": "data/MARIO MESTAZ/Progress Note_2025-07-01_1_4_5.pdf"}, "61935742-e908-46a0-a210-a06dc35272aa": {"doc_hash": "1930887b48961c4496e0fb87619c7b7478a21494432a8e172258bea9dc54463e", "ref_doc_id": "data/MARIO MESTAZ/Progress Note_2025-07-01_1_4_5.pdf"}, "f86fac39-3683-453e-9dc8-ee52ef3f4954": {"doc_hash": "712f2d9c92b516346902fc6ec031b83aa04ca7fc9fc62e161af27dd756bc7bfb", "ref_doc_id": "data/MARIO MESTAZ/NEW Progress Note (1).pdf"}, "df07661d-c472-4d65-b580-b35f0766559b": {"doc_hash": "f3204ad3411e72182a564ec121b6c7096fbeac440905b57e32f321b193e9c7fa", "ref_doc_id": "data/MARIO MESTAZ/NEW Progress Note (1).pdf"}, "c2756e1e-cb45-4358-a3aa-10313a24cf93": {"doc_hash": "880cb8a3577c5d9ace8e4f62f84c27ead10a1f61afbadc4f9d02a0d0f1eb83d2", "ref_doc_id": "data/MARIO MESTAZ/NEW Progress Note (1).pdf"}, "7357ea1e-78d7-4f56-b5dd-28448fe78000": {"doc_hash": "575981d8f955d376e395a59c0831021acfa4450c6113b64ec8af3646ad1cb80f", "ref_doc_id": "data/MARIO MESTAZ/NEW Progress Note (1).pdf"}, "a01c34ee-733b-4dd2-a997-0bb319ee7b4a": {"doc_hash": "980b4f9eab2b396388ef7cda900f68b19dd9b4c90b3877f50830812fe39e0dcf", "ref_doc_id": "data/MARIO MESTAZ/Manual_2025-07-01_3_1_5.pdf"}}, "docstore/ref_doc_info": {"data/MARIO MESTAZ/Progress Note_2025-07-01_1_4_5.pdf": {"node_ids": ["6c03fdee-df34-43f3-839d-e63aa9fd91c1", "16ebdd77-0c55-4efc-8881-048402345460", "5b04fd55-7c84-435d-993d-c276bd314b7f", "61935742-e908-46a0-a210-a06dc35272aa"], "metadata": {}}, "data/MARIO MESTAZ/NEW Progress Note (1).pdf": {"node_ids": ["f86fac39-3683-453e-9dc8-ee52ef3f4954", "df07661d-c472-4d65-b580-b35f0766559b", "c2756e1e-cb45-4358-a3aa-10313a24cf93", "7357ea1e-78d7-4f56-b5dd-28448fe78000"], "metadata": {}}, "data/MARIO MESTAZ/Manual_2025-07-01_3_1_5.pdf": {"node_ids": ["a01c34ee-733b-4dd2-a997-0bb319ee7b4a"], "metadata": {}}}, "docstore/data": {"6c03fdee-df34-43f3-839d-e63aa9fd91c1": {"__data__": {"id_": "6c03fdee-df34-43f3-839d-e63aa9fd91c1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "data/MARIO MESTAZ/Progress Note_2025-07-01_1_4_5.pdf", "node_type": "4", "metadata": {}, "hash": "13750aec692d5065ebe4cec430353eb9398e052481de54ae2f6d90bdde153cce", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "16ebdd77-0c55-4efc-8881-048402345460", "node_type": "1", "metadata": {}, "hash": "553bce47e047bb64b1c245ab73ab0c2704168239b795aee8bcfbb482b66a7c0a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Sanjaya Khanal, MD\n43723 20th Street West, Lancaster, CA 93534  Phone: (661) 674-4222  Fax: (661) 674-4211\n \nMario L. Mestaz  (DOB  06/04/1963) Date of Encounter:    04/23/2025\n \n \nHistory of Present Illness    \nThe patient is a 61 year old male who presents to discuss laboratory test results. The blood was drawn on: Date:\n(01/28/2025).   He is planning to undergo gallbladder surgery.  He denies any chest pain or shortness of breath.\nAdditional reasons for visit:\nTransition into care  is described as the following:\nNote for \"Transition into care\": to continue cardiac care.\nAllergies\nNo Known Drug Allergies  11/15/2021\n \nPast Medical History\nGout of wrist\nChronic abdominal pain\nHistory of COVID-19\nH/O TIA (transient ischemic attack) and stroke\nChest pain, central\nPVC (premature ventricular contraction) ; as mentioned above he also has frequent PVCs with a burden of\n2.7%. improved to 0.93% in December 2002.\nEssential hypertension\nDyslipidemia\nHypothyroidism, adult\nTIA (transient ischemic attack) ; he was admitted then to evaluate hospital on November 27, 2021 with\nsymptoms suggestive of TIA. MRI of the brain was negative. Carotid arteries showed no obstructive disease by CT\nand jaw. he had a recurrent episode in April 2022.\nParoxysmal atrial fibrillation ; MPI in 2022 was normal with no ischemia. A seven-day patch monitor in April\n2022. Predominantly sinus rhythm with paroxysmal atrial fibrillation and rapid ventricle response up to 29 beats\nwith aberrant conduction. He also had frequent PVCs of 2.7% and nonsustained ventricular tachycardia. MPI on\n3/2/2022 was normal with LVEF of 65%. monitor done in December 2023 shows no atrial fibrillation with PVCs of\n0.93%. Echocardiogram on 3/26/2024 showed LVEF of 55 to 60% with mildly dilated left atrium.\nFibromyalgia\nOSA (obstructive sleep apnea)\n \nSocial History\nAlcohol use : Never Drinks\nTobacco use : Never smoker\nCaffeine use : Coffee, 1 serving / day; Decaf\nMarital status : Divorced; 4 daughters\nCurrent work status : Retired; Automotive\n \n Tuesday, July 1, 2025   Page 1 / 5  \nMedication History\nmetoprolol succinate (50mg Tablet, Extende, 1 oral daily, Taken starting 04/11/2025) Active.\nlosartan-hydrochlorothiazide (50-12.5mg tablet, 1 oral daily, Taken starting 07/24/2024) Active.\natorvastatin (40mg tablet, 1 oral daily, Taken starting 07/24/2024) Active.\namLODIPine (5mg tablet, 1 oral daily, Taken starting 07/24/2024) Active.\nflecainide (100mg tablet, 1 (one) oral BID, Taken starting 03/04/2025) Active.\nEliquis (5mg tablet, 1 (one) oral BID, Taken starting 03/27/2025) Active.\nGabapentin (800mg tablet, 1 oral two times daily, as needed) Active.\nLevothyroxine Sodium (100MCG capsule, 1 Oral daily) Active.\nAllopurinol (100MG tablet, 1 Oral daily) Active.\nDULoxetine HCl (30MG capsule,delayed, 1 Oral daily) Active.\nFish Oil (1000MG capsule, 1 Oral daily) Active.\nVitamin D3 (1.25 MG(50000 UT) capsule, 1 Oral once a week) Active.\nCyclobenzaprine HCl (10MG tablet, 1 Oral three times daily) Active.\ntraMADol HCl (50MG tablet, 1 Oral three times daily) Active.\nLyrica (50mg capsule, 1 oral two times daily) Active.\nalendronate (70mg tablet, oral weekly) Active.\nibuprofen (800mg tablet, 1 oral as needed) Active.\ntraZODone (100mg tablet, 1 oral daily) Active.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3248, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "16ebdd77-0c55-4efc-8881-048402345460": {"__data__": {"id_": "16ebdd77-0c55-4efc-8881-048402345460", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "data/MARIO MESTAZ/Progress Note_2025-07-01_1_4_5.pdf", "node_type": "4", "metadata": {}, "hash": "13750aec692d5065ebe4cec430353eb9398e052481de54ae2f6d90bdde153cce", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6c03fdee-df34-43f3-839d-e63aa9fd91c1", "node_type": "1", "metadata": {}, "hash": "712f2d9c92b516346902fc6ec031b83aa04ca7fc9fc62e161af27dd756bc7bfb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5b04fd55-7c84-435d-993d-c276bd314b7f", "node_type": "1", "metadata": {}, "hash": "e5dd83b1c1b652bbcdf613e9282874b9106236dc2802c3a2c0c8d0443bfddadd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Levothyroxine Sodium (100MCG capsule, 1 Oral daily) Active.\nAllopurinol (100MG tablet, 1 Oral daily) Active.\nDULoxetine HCl (30MG capsule,delayed, 1 Oral daily) Active.\nFish Oil (1000MG capsule, 1 Oral daily) Active.\nVitamin D3 (1.25 MG(50000 UT) capsule, 1 Oral once a week) Active.\nCyclobenzaprine HCl (10MG tablet, 1 Oral three times daily) Active.\ntraMADol HCl (50MG tablet, 1 Oral three times daily) Active.\nLyrica (50mg capsule, 1 oral two times daily) Active.\nalendronate (70mg tablet, oral weekly) Active.\nibuprofen (800mg tablet, 1 oral as needed) Active.\ntraZODone (100mg tablet, 1 oral daily) Active.\nbaclofen (5mg tablet, 1 oral two times daily) Active.\nMedications Reconciled.\n \nPast Surgical\nArthroscopic Knee Surgery - Left : Date: 1993\nThyroidectomy; Total : Date: 2/14/2012\nColon Removal - Partial : Date: 2/15/2019\nInguinal Hernia Repair-Bilateral : Date: 11/1/2019\n \nReview of Systems   \nSkin Not Present- Bruising, Itching and Rash.\nHEENT  Present- Wears glasses/contact lenses . Not Present- Blurred Vision, Dentures, Headache, Hearing Loss, Loose\nteeth, Nasal polyps, Nose Bleed, Permanent blindness in either eye, Sore Throat and Vertigo.\nNeck  Not Present- Neck Pain and Neck Stiffness.\nRespiratory  Not Present- Bloody sputum, Cough, Decreased Exercise Tolerance, Difficulty Breathing, Hemoptysis, Recent\nbronchitis or chest cold, Sputum Production and Wheezing.\nCardiovascular  Present- Chest Pain , Require more than one pillow at night to breathe  and Shortness of Breath .\nNot Present- Awakening at night gasping for air or short of breath, Calf Cramps, Claudications, Difficulty Breathing Lying\nDown, Difficulty Breathing On Exertion, Discoloration of feet and legs, Fainting / Blacking Out, Leg Cramps, Palpitations and\nSwelling of Extremities.\nGastrointestinal  Present- Abdominal Pain  and Heartburn . Not Present- Bloody Stool, Constipation, Diarrhea, Dysphagia,\nIndigestion, Nausea and Vomiting.\nMusculoskeletal  Present- Joint Pain . Not Present- Back Pain, Joint Swelling, Muscle Atrophy and Muscle Pain.\nNeurological  Not Present- Decreased Memory, Difficulty Speaking, Dizziness, Epilepsy or seizures, Fainting, Headaches,\nIncontinence Urine, Loss of Consciousness, Migraines, Numbness, Paresthesias, Sudden visual disturbances in either eye,\nTemporary blindness in either eye, Temporary speech loss or difficulty talking, Tremor, Trouble walking, Unsteadiness and\nWeakness or paralysis of one side of the body.\nEndocrine  Not Present- Appetite Changes, Excessive Thirst, Excessive Urination and Recent weight gain or loss(>10 lbs.).\nHematology  Present- Easy Bruising . Not Present- Abnormal Bleeding, Anemia, Excessive bleeding, Nose Bleed and Recent\nfever.\nVitals \n Tuesday, July 1, 2025   Page 2 / 5  \nPoint of Maximal Impulse - Normal.\nAuscultation\nRhythm - Regular. Heart Sounds - S1 WNL and S2 WNL, No S3, No S4. Murmurs & Other Heart Sounds -\nAuscultation of the heart reveals - No Murmurs.\nAbdomen\nPalpation/Percussion\nPalpation and Percussion of the abdomen reveal - Non Tender. Liver - Other Characteristics - No\nHepatomegaly. Spleen - Other Characteristics - No Splenomegaly.\nAuscultation\nAuscultation of the abdomen reveals - Bowel sounds normal and No Abdominal bruits.\nRectal\nAnorectal Exam\nResidue - Occult blood testing is not indicated for this patient.\nPeripheral Vascular\nLower Extremity\nPalpation - Bilateral - Femoral pulse - Normal - Bilateral. Dorsalis pedis pulse - Bilateral - Normal - Bilateral.\nEdema - Bilateral - No edema - Bilateral.\nNeurologic\nMotor - Normal.", "mimetype": "text/plain", "start_char_idx": 2637, "end_char_idx": 6167, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5b04fd55-7c84-435d-993d-c276bd314b7f": {"__data__": {"id_": "5b04fd55-7c84-435d-993d-c276bd314b7f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "data/MARIO MESTAZ/Progress Note_2025-07-01_1_4_5.pdf", "node_type": "4", "metadata": {}, "hash": "13750aec692d5065ebe4cec430353eb9398e052481de54ae2f6d90bdde153cce", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "16ebdd77-0c55-4efc-8881-048402345460", "node_type": "1", "metadata": {}, "hash": "553bce47e047bb64b1c245ab73ab0c2704168239b795aee8bcfbb482b66a7c0a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "61935742-e908-46a0-a210-a06dc35272aa", "node_type": "1", "metadata": {}, "hash": "1930887b48961c4496e0fb87619c7b7478a21494432a8e172258bea9dc54463e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Murmurs & Other Heart Sounds -\nAuscultation of the heart reveals - No Murmurs.\nAbdomen\nPalpation/Percussion\nPalpation and Percussion of the abdomen reveal - Non Tender. Liver - Other Characteristics - No\nHepatomegaly. Spleen - Other Characteristics - No Splenomegaly.\nAuscultation\nAuscultation of the abdomen reveals - Bowel sounds normal and No Abdominal bruits.\nRectal\nAnorectal Exam\nResidue - Occult blood testing is not indicated for this patient.\nPeripheral Vascular\nLower Extremity\nPalpation - Bilateral - Femoral pulse - Normal - Bilateral. Dorsalis pedis pulse - Bilateral - Normal - Bilateral.\nEdema - Bilateral - No edema - Bilateral.\nNeurologic\nMotor - Normal.\nMusculoskeletal\nGlobal Assessment\nGait and Station - normal gait and station and normal posture. Head and Neck - normal strength and tone, no\nlaxity. Spine, Ribs and Pelvis - no deformities, malalignments, masses or tenderness, no known fractures.\nRight Lower Extremity - normal strength and tone. Left Lower Extremity - normal strength and tone.\nAssessment & Plan  \nPreop cardiovascular exam\nProblem Story: He is planned to undergo gallbladder surgery.\nToday's Impression: He has lower risk clinical predictors and no cardiac contraindications to proceed with surgery\nas planned. Eliquis can be held for 2 days prior to the surgery but he should continue all the other medications.\nParoxysmal atrial fibrillation\nProblem Story: MPI in 2022 was normal with no ischemia. A seven-day patch monitor in April 2022. Predominantly\nsinus rhythm with paroxysmal atrial fibrillation and rapid ventricle response up to 29 beats with aberrant conduction.\nHe also had frequent PVCs of 2.7% and nonsustained ventricular tachycardia. MPI on 3/2/2022 was normal with\nLVEF of 65%. monitor done in December 2023 shows no atrial fibrillation with PVCs of 0.93%. Echocardiogram on\n3/26/2024 showed LVEF of 55 to 60% with mildly dilated left atrium.\nToday's Impression: He is arrhythmia is clinically improved. He should continue Eliquis for anti-coagulation. He\nhas easy bruisability and has affordability issues with Eliquis. He wants to consider Watchman device placement. I\nhave described to him the procedure, risks, benefits, and alternatives including a small risk of bleeding, infection,\narrhythmia, injury to the blood vessels, heart, lung etc. and is willing to proceed.\nINSERTION, WATCHMAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE (33340) ; Routine ()\nContinued Eliquis 5 mg tablet, 1 (one) Tablet BID, #180, 90 days starting 04/23/2025, Ref. x3.\nContinued flecainide 100 mg tablet, 1 (one) Tablet BID, #180, 90 days starting 04/23/2025, Ref. x3.\nFollow up in 6 months or as needed\n Tuesday, July 1, 2025   Page 4 / 5  \nPVC (premature ventricular contraction)\nProblem Story: as mentioned above he also has frequent PVCs with a burden of 2.7%. improved to 0.93% in\nDecember 2002.\nToday's Impression: he is on flecainide.\nEssential hypertension\nToday's Impression: blood pressure is well controlled. since he has lost weight I have reduced the dose of his\nmetoprolol to 50 mg daily.\nContinued amLODIPine 5 mg tablet, 1 daily, 04/23/2025, No Refill.\nContinued metoprolol succinate ER 50 mg tablet,extended release 24 hr, 1 Tablet daily, #90, 90 days\nstarting 04/23/2025, Ref. x3.\nContinued losartan 50 mg-hydrochlorothiazide 12.5 mg tablet, 1 Tablet daily, #90, 90 days starting\n04/23/2025, Ref. Q 90 Days x1 Year.\nDyslipidemia\nToday's Impression: lipids are controlled.", "mimetype": "text/plain", "start_char_idx": 5496, "end_char_idx": 8922, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "61935742-e908-46a0-a210-a06dc35272aa": {"__data__": {"id_": "61935742-e908-46a0-a210-a06dc35272aa", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "data/MARIO MESTAZ/Progress Note_2025-07-01_1_4_5.pdf", "node_type": "4", "metadata": {}, "hash": "13750aec692d5065ebe4cec430353eb9398e052481de54ae2f6d90bdde153cce", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5b04fd55-7c84-435d-993d-c276bd314b7f", "node_type": "1", "metadata": {}, "hash": "e5dd83b1c1b652bbcdf613e9282874b9106236dc2802c3a2c0c8d0443bfddadd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Today's Impression: he is on flecainide.\nEssential hypertension\nToday's Impression: blood pressure is well controlled. since he has lost weight I have reduced the dose of his\nmetoprolol to 50 mg daily.\nContinued amLODIPine 5 mg tablet, 1 daily, 04/23/2025, No Refill.\nContinued metoprolol succinate ER 50 mg tablet,extended release 24 hr, 1 Tablet daily, #90, 90 days\nstarting 04/23/2025, Ref. x3.\nContinued losartan 50 mg-hydrochlorothiazide 12.5 mg tablet, 1 Tablet daily, #90, 90 days starting\n04/23/2025, Ref. Q 90 Days x1 Year.\nDyslipidemia\nToday's Impression: lipids are controlled.\nCHEM 7 (80048); Routine () \nLIPID PANEL (80061); Routine () \nLIVER PANEL (80076); Routine () \nHGB A1C (83036); Routine () \nTSH (THYROID STIMULATING HORMONE) (84443); Routine () \nFREE T4 (84439); Routine () \nContinued atorvastatin 40 mg tablet, 1 Tablet daily, #90, 90 days starting 04/23/2025, Ref. x3.\nHypothyroidism, adult\nTIA (transient ischemic attack)\nProblem Story: he was admitted then to evaluate hospital on November 27, 2021 with symptoms suggestive of\nTIA. MRI of the brain was negative. Carotid arteries showed no obstructive disease by CT and jaw. he had a\nrecurrent episode in April 2022.\nToday's Impression: I have switched him to Eliquis as mentioned above. He understands the risks versus benefit\nof anticoagulation.\nFibromyalgia\nOSA (obstructive sleep apnea)\n \n \nSanjaya Khanal, MD\n \nElectronically Signed\n Tuesday, July 1, 2025   Page 5 / 5", "mimetype": "text/plain", "start_char_idx": 8334, "end_char_idx": 9782, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f86fac39-3683-453e-9dc8-ee52ef3f4954": {"__data__": {"id_": "f86fac39-3683-453e-9dc8-ee52ef3f4954", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "data/MARIO MESTAZ/NEW Progress Note (1).pdf", "node_type": "4", "metadata": {}, "hash": "39be74e153f69c227da3c9b8dd93cf6a1679b8c70edeaf1ca77b821367be98d6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "df07661d-c472-4d65-b580-b35f0766559b", "node_type": "1", "metadata": {}, "hash": "f3204ad3411e72182a564ec121b6c7096fbeac440905b57e32f321b193e9c7fa", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Sanjaya Khanal, MD\n43723 20th Street West, Lancaster, CA 93534  Phone: (661) 674-4222  Fax: (661) 674-4211\n \nMario L. Mestaz  (DOB  06/04/1963) Date of Encounter:    04/23/2025\n \n \nHistory of Present Illness    \nThe patient is a 61 year old male who presents to discuss laboratory test results. The blood was drawn on: Date:\n(01/28/2025).   He is planning to undergo gallbladder surgery.  He denies any chest pain or shortness of breath.\nAdditional reasons for visit:\nTransition into care  is described as the following:\nNote for \"Transition into care\": to continue cardiac care.\nAllergies\nNo Known Drug Allergies  11/15/2021\n \nPast Medical History\nGout of wrist\nChronic abdominal pain\nHistory of COVID-19\nH/O TIA (transient ischemic attack) and stroke\nChest pain, central\nPVC (premature ventricular contraction) ; as mentioned above he also has frequent PVCs with a burden of\n2.7%. improved to 0.93% in December 2002.\nEssential hypertension\nDyslipidemia\nHypothyroidism, adult\nTIA (transient ischemic attack) ; he was admitted then to evaluate hospital on November 27, 2021 with\nsymptoms suggestive of TIA. MRI of the brain was negative. Carotid arteries showed no obstructive disease by CT\nand jaw. he had a recurrent episode in April 2022.\nParoxysmal atrial fibrillation ; MPI in 2022 was normal with no ischemia. A seven-day patch monitor in April\n2022. Predominantly sinus rhythm with paroxysmal atrial fibrillation and rapid ventricle response up to 29 beats\nwith aberrant conduction. He also had frequent PVCs of 2.7% and nonsustained ventricular tachycardia. MPI on\n3/2/2022 was normal with LVEF of 65%. monitor done in December 2023 shows no atrial fibrillation with PVCs of\n0.93%. Echocardiogram on 3/26/2024 showed LVEF of 55 to 60% with mildly dilated left atrium.\nFibromyalgia\nOSA (obstructive sleep apnea)\n \nSocial History\nAlcohol use : Never Drinks\nTobacco use : Never smoker\nCaffeine use : Coffee, 1 serving / day; Decaf\nMarital status : Divorced; 4 daughters\nCurrent work status : Retired; Automotive\n \n Tuesday, July 1, 2025   Page 1 / 5  \nMedication History\nmetoprolol succinate (50mg Tablet, Extende, 1 oral daily, Taken starting 04/11/2025) Active.\nlosartan-hydrochlorothiazide (50-12.5mg tablet, 1 oral daily, Taken starting 07/24/2024) Active.\natorvastatin (40mg tablet, 1 oral daily, Taken starting 07/24/2024) Active.\namLODIPine (5mg tablet, 1 oral daily, Taken starting 07/24/2024) Active.\nflecainide (100mg tablet, 1 (one) oral BID, Taken starting 03/04/2025) Active.\nEliquis (5mg tablet, 1 (one) oral BID, Taken starting 03/27/2025) Active.\nGabapentin (800mg tablet, 1 oral two times daily, as needed) Active.\nLevothyroxine Sodium (100MCG capsule, 1 Oral daily) Active.\nAllopurinol (100MG tablet, 1 Oral daily) Active.\nDULoxetine HCl (30MG capsule,delayed, 1 Oral daily) Active.\nFish Oil (1000MG capsule, 1 Oral daily) Active.\nVitamin D3 (1.25 MG(50000 UT) capsule, 1 Oral once a week) Active.\nCyclobenzaprine HCl (10MG tablet, 1 Oral three times daily) Active.\ntraMADol HCl (50MG tablet, 1 Oral three times daily) Active.\nLyrica (50mg capsule, 1 oral two times daily) Active.\nalendronate (70mg tablet, oral weekly) Active.\nibuprofen (800mg tablet, 1 oral as needed) Active.\ntraZODone (100mg tablet, 1 oral daily) Active.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3248, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "df07661d-c472-4d65-b580-b35f0766559b": {"__data__": {"id_": "df07661d-c472-4d65-b580-b35f0766559b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "data/MARIO MESTAZ/NEW Progress Note (1).pdf", "node_type": "4", "metadata": {}, "hash": "39be74e153f69c227da3c9b8dd93cf6a1679b8c70edeaf1ca77b821367be98d6", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f86fac39-3683-453e-9dc8-ee52ef3f4954", "node_type": "1", "metadata": {}, "hash": "712f2d9c92b516346902fc6ec031b83aa04ca7fc9fc62e161af27dd756bc7bfb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c2756e1e-cb45-4358-a3aa-10313a24cf93", "node_type": "1", "metadata": {}, "hash": "880cb8a3577c5d9ace8e4f62f84c27ead10a1f61afbadc4f9d02a0d0f1eb83d2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Levothyroxine Sodium (100MCG capsule, 1 Oral daily) Active.\nAllopurinol (100MG tablet, 1 Oral daily) Active.\nDULoxetine HCl (30MG capsule,delayed, 1 Oral daily) Active.\nFish Oil (1000MG capsule, 1 Oral daily) Active.\nVitamin D3 (1.25 MG(50000 UT) capsule, 1 Oral once a week) Active.\nCyclobenzaprine HCl (10MG tablet, 1 Oral three times daily) Active.\ntraMADol HCl (50MG tablet, 1 Oral three times daily) Active.\nLyrica (50mg capsule, 1 oral two times daily) Active.\nalendronate (70mg tablet, oral weekly) Active.\nibuprofen (800mg tablet, 1 oral as needed) Active.\ntraZODone (100mg tablet, 1 oral daily) Active.\nbaclofen (5mg tablet, 1 oral two times daily) Active.\nMedications Reconciled.\n \nPast Surgical\nArthroscopic Knee Surgery - Left : Date: 1993\nThyroidectomy; Total : Date: 2/14/2012\nColon Removal - Partial : Date: 2/15/2019\nInguinal Hernia Repair-Bilateral : Date: 11/1/2019\n \nReview of Systems   \nSkin Not Present- Bruising, Itching and Rash.\nHEENT  Present- Wears glasses/contact lenses . Not Present- Blurred Vision, Dentures, Headache, Hearing Loss, Loose\nteeth, Nasal polyps, Nose Bleed, Permanent blindness in either eye, Sore Throat and Vertigo.\nNeck  Not Present- Neck Pain and Neck Stiffness.\nRespiratory  Not Present- Bloody sputum, Cough, Decreased Exercise Tolerance, Difficulty Breathing, Hemoptysis, Recent\nbronchitis or chest cold, Sputum Production and Wheezing.\nCardiovascular  Present- Chest Pain , Require more than one pillow at night to breathe  and Shortness of Breath .\nNot Present- Awakening at night gasping for air or short of breath, Calf Cramps, Claudications, Difficulty Breathing Lying\nDown, Difficulty Breathing On Exertion, Discoloration of feet and legs, Fainting / Blacking Out, Leg Cramps, Palpitations and\nSwelling of Extremities.\nGastrointestinal  Present- Abdominal Pain  and Heartburn . Not Present- Bloody Stool, Constipation, Diarrhea, Dysphagia,\nIndigestion, Nausea and Vomiting.\nMusculoskeletal  Present- Joint Pain . Not Present- Back Pain, Joint Swelling, Muscle Atrophy and Muscle Pain.\nNeurological  Not Present- Decreased Memory, Difficulty Speaking, Dizziness, Epilepsy or seizures, Fainting, Headaches,\nIncontinence Urine, Loss of Consciousness, Migraines, Numbness, Paresthesias, Sudden visual disturbances in either eye,\nTemporary blindness in either eye, Temporary speech loss or difficulty talking, Tremor, Trouble walking, Unsteadiness and\nWeakness or paralysis of one side of the body.\nEndocrine  Not Present- Appetite Changes, Excessive Thirst, Excessive Urination and Recent weight gain or loss(>10 lbs.).\nHematology  Present- Easy Bruising . Not Present- Abnormal Bleeding, Anemia, Excessive bleeding, Nose Bleed and Recent\nfever.\nVitals \n Tuesday, July 1, 2025   Page 2 / 5  \n04/23/2025 01:03 PM\nWeight: 148 lb Height: 67 in \nBody Surface Area:  1.78 m\u00b2   Body Mass Index:  23.18 kg/m\u00b2  \nPulse: 76 (Regular)  P. OX: 98% (Room air)  \nBP: 109/62 Manual  (Sitting, Left Arm, Standard)\nPhysical Exam\nThe physical exam findings are as follows:\nGeneral\nMental Status - Alert.\nGeneral Appearance - Cooperative, Not in acute distress, Not Sickly.\nOrientation - Oriented X4.\nBuild & Nutrition - Well nourished and Well developed.\nIntegumentary\nGlobal Assessment\nExamination of related systems reveals - Examination of digits and nails reveals no abnormalities, no digital\nclubbing, cyanosis or petechiae.\nGeneral Characteristics\nColor - normal coloration of skin. Skin Moisture - normal skin moisture.\nHead and Neck\nNeck\nCarotid Arteries - Bilateral - normal upstroke and runoff.\nThyroid\nGland Characteristics - normal size and consistency.\nEye\nFundi - Bilateral - Normal.", "mimetype": "text/plain", "start_char_idx": 2637, "end_char_idx": 6269, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c2756e1e-cb45-4358-a3aa-10313a24cf93": {"__data__": {"id_": "c2756e1e-cb45-4358-a3aa-10313a24cf93", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "data/MARIO MESTAZ/NEW Progress Note (1).pdf", "node_type": "4", "metadata": {}, "hash": "39be74e153f69c227da3c9b8dd93cf6a1679b8c70edeaf1ca77b821367be98d6", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "df07661d-c472-4d65-b580-b35f0766559b", "node_type": "1", "metadata": {}, "hash": "f3204ad3411e72182a564ec121b6c7096fbeac440905b57e32f321b193e9c7fa", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7357ea1e-78d7-4f56-b5dd-28448fe78000", "node_type": "1", "metadata": {}, "hash": "575981d8f955d376e395a59c0831021acfa4450c6113b64ec8af3646ad1cb80f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "General Appearance - Cooperative, Not in acute distress, Not Sickly.\nOrientation - Oriented X4.\nBuild & Nutrition - Well nourished and Well developed.\nIntegumentary\nGlobal Assessment\nExamination of related systems reveals - Examination of digits and nails reveals no abnormalities, no digital\nclubbing, cyanosis or petechiae.\nGeneral Characteristics\nColor - normal coloration of skin. Skin Moisture - normal skin moisture.\nHead and Neck\nNeck\nCarotid Arteries - Bilateral - normal upstroke and runoff.\nThyroid\nGland Characteristics - normal size and consistency.\nEye\nFundi - Bilateral - Normal.\nSclera/Conjunctiva - Bilateral - Normal.\nENMT\nMouth and Throat\nOral Cavity/Oropharynx - Gingiva - no inflammation present.\nChest and Lung Exam\nInspection\nShape - Normal. Accessory muscles - No use of accessory muscles in breathing.\nAuscultation\nBreath sounds - Normal. Adventitious sounds - No Adventitious sounds.\nCardiovascular\nInspection\nBP In 2+ Extremities - Not Indicated.\nPalpation/Percussion\n Tuesday, July 1, 2025   Page 3 / 5  \nPoint of Maximal Impulse - Normal.\nAuscultation\nRhythm - Regular. Heart Sounds - S1 WNL and S2 WNL, No S3, No S4. Murmurs & Other Heart Sounds -\nAuscultation of the heart reveals - No Murmurs.\nAbdomen\nPalpation/Percussion\nPalpation and Percussion of the abdomen reveal - Non Tender. Liver - Other Characteristics - No\nHepatomegaly. Spleen - Other Characteristics - No Splenomegaly.\nAuscultation\nAuscultation of the abdomen reveals - Bowel sounds normal and No Abdominal bruits.\nRectal\nAnorectal Exam\nResidue - Occult blood testing is not indicated for this patient.\nPeripheral Vascular\nLower Extremity\nPalpation - Bilateral - Femoral pulse - Normal - Bilateral. Dorsalis pedis pulse - Bilateral - Normal - Bilateral.\nEdema - Bilateral - No edema - Bilateral.\nNeurologic\nMotor - Normal.\nMusculoskeletal\nGlobal Assessment\nGait and Station - normal gait and station and normal posture. Head and Neck - normal strength and tone, no\nlaxity. Spine, Ribs and Pelvis - no deformities, malalignments, masses or tenderness, no known fractures.\nRight Lower Extremity - normal strength and tone. Left Lower Extremity - normal strength and tone.\nAssessment & Plan  \nPreop cardiovascular exam\nProblem Story: He is planned to undergo gallbladder surgery.\nToday's Impression: He has lower risk clinical predictors and no cardiac contraindications to proceed with surgery\nas planned. Eliquis can be held for 2 days prior to the surgery but he should continue all the other medications.\nParoxysmal atrial fibrillation\nProblem Story: MPI in 2022 was normal with no ischemia. A seven-day patch monitor in April 2022. Predominantly\nsinus rhythm with paroxysmal atrial fibrillation and rapid ventricle response up to 29 beats with aberrant conduction.\nHe also had frequent PVCs of 2.7% and nonsustained ventricular tachycardia. MPI on 3/2/2022 was normal with\nLVEF of 65%. monitor done in December 2023 shows no atrial fibrillation with PVCs of 0.93%. Echocardiogram on\n3/26/2024 showed LVEF of 55 to 60% with mildly dilated left atrium.\nToday's Impression: He is arrhythmia is clinically improved. He should continue Eliquis for anti-coagulation. He\nhas easy bruisability and has affordability issues with Eliquis. He wants to consider Watchman device placement. I\nhave described to him the procedure, risks, benefits, and alternatives including a small risk of bleeding, infection,\narrhythmia, injury to the blood vessels, heart, lung etc. and is willing to proceed.\nINSERTION, WATCHMAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE (33340) ; Routine ()\nContinued Eliquis 5 mg tablet, 1 (one) Tablet BID, #180, 90 days starting 04/23/2025, Ref. x3.\nContinued flecainide 100 mg tablet, 1 (one) Tablet BID, #180, 90 days starting 04/23/2025, Ref.", "mimetype": "text/plain", "start_char_idx": 5676, "end_char_idx": 9423, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7357ea1e-78d7-4f56-b5dd-28448fe78000": {"__data__": {"id_": "7357ea1e-78d7-4f56-b5dd-28448fe78000", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "data/MARIO MESTAZ/NEW Progress Note (1).pdf", "node_type": "4", "metadata": {}, "hash": "39be74e153f69c227da3c9b8dd93cf6a1679b8c70edeaf1ca77b821367be98d6", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c2756e1e-cb45-4358-a3aa-10313a24cf93", "node_type": "1", "metadata": {}, "hash": "880cb8a3577c5d9ace8e4f62f84c27ead10a1f61afbadc4f9d02a0d0f1eb83d2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Today's Impression: He is arrhythmia is clinically improved. He should continue Eliquis for anti-coagulation. He\nhas easy bruisability and has affordability issues with Eliquis. He wants to consider Watchman device placement. I\nhave described to him the procedure, risks, benefits, and alternatives including a small risk of bleeding, infection,\narrhythmia, injury to the blood vessels, heart, lung etc. and is willing to proceed.\nINSERTION, WATCHMAN LEFT ATRIAL APPENDAGE CLOSURE DEVICE (33340) ; Routine ()\nContinued Eliquis 5 mg tablet, 1 (one) Tablet BID, #180, 90 days starting 04/23/2025, Ref. x3.\nContinued flecainide 100 mg tablet, 1 (one) Tablet BID, #180, 90 days starting 04/23/2025, Ref. x3.\nFollow up in 6 months or as needed\n Tuesday, July 1, 2025   Page 4 / 5  \nPVC (premature ventricular contraction)\nProblem Story: as mentioned above he also has frequent PVCs with a burden of 2.7%. improved to 0.93% in\nDecember 2002.\nToday's Impression: he is on flecainide.\nEssential hypertension\nToday's Impression: blood pressure is well controlled. since he has lost weight I have reduced the dose of his\nmetoprolol to 50 mg daily.\nContinued amLODIPine 5 mg tablet, 1 daily, 04/23/2025, No Refill.\nContinued metoprolol succinate ER 50 mg tablet,extended release 24 hr, 1 Tablet daily, #90, 90 days\nstarting 04/23/2025, Ref. x3.\nContinued losartan 50 mg-hydrochlorothiazide 12.5 mg tablet, 1 Tablet daily, #90, 90 days starting\n04/23/2025, Ref. Q 90 Days x1 Year.\nDyslipidemia\nToday's Impression: lipids are controlled.\nCHEM 7 (80048); Routine () \nLIPID PANEL (80061); Routine () \nLIVER PANEL (80076); Routine () \nHGB A1C (83036); Routine () \nTSH (THYROID STIMULATING HORMONE) (84443); Routine () \nFREE T4 (84439); Routine () \nContinued atorvastatin 40 mg tablet, 1 Tablet daily, #90, 90 days starting 04/23/2025, Ref. x3.\nHypothyroidism, adult\nTIA (transient ischemic attack)\nProblem Story: he was admitted then to evaluate hospital on November 27, 2021 with symptoms suggestive of\nTIA. MRI of the brain was negative. Carotid arteries showed no obstructive disease by CT and jaw. he had a\nrecurrent episode in April 2022.\nToday's Impression: I have switched him to Eliquis as mentioned above. He understands the risks versus benefit\nof anticoagulation.\nFibromyalgia\nOSA (obstructive sleep apnea)\n \n \nSanjaya Khanal, MD\n \nElectronically Signed\n Tuesday, July 1, 2025   Page 5 / 5", "mimetype": "text/plain", "start_char_idx": 8724, "end_char_idx": 11108, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a01c34ee-733b-4dd2-a997-0bb319ee7b4a": {"__data__": {"id_": "a01c34ee-733b-4dd2-a997-0bb319ee7b4a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "data/MARIO MESTAZ/Manual_2025-07-01_3_1_5.pdf", "node_type": "4", "metadata": {}, "hash": "53770b1f7171389e7a80173ca691e8bf14d08f9595ad1143b6f3362f97c2b57a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "04/23/2025 01:03 PM\nWeight: 148 lb Height: 67 in \nBody Surface Area:  1.78 m\u00b2   Body Mass Index:  23.18 kg/m\u00b2  \nPulse: 76 (Regular)  P. OX: 98% (Room air)  \nBP: 109/62 Manual  (Sitting, Left Arm, Standard)\nPhysical Exam\nThe physical exam findings are as follows:\nGeneral\nMental Status - Alert.\nGeneral Appearance - Cooperative, Not in acute distress, Not Sickly.\nOrientation - Oriented X4.\nBuild & Nutrition - Well nourished and Well developed.\nIntegumentary\nGlobal Assessment\nExamination of related systems reveals - Examination of digits and nails reveals no abnormalities, no digital\nclubbing, cyanosis or petechiae.\nGeneral Characteristics\nColor - normal coloration of skin. Skin Moisture - normal skin moisture.\nHead and Neck\nNeck\nCarotid Arteries - Bilateral - normal upstroke and runoff.\nThyroid\nGland Characteristics - normal size and consistency.\nEye\nFundi - Bilateral - Normal.\nSclera/Conjunctiva - Bilateral - Normal.\nENMT\nMouth and Throat\nOral Cavity/Oropharynx - Gingiva - no inflammation present.\nChest and Lung Exam\nInspection\nShape - Normal. Accessory muscles - No use of accessory muscles in breathing.\nAuscultation\nBreath sounds - Normal. Adventitious sounds - No Adventitious sounds.\nCardiovascular\nInspection\nBP In 2+ Extremities - Not Indicated.\nPalpation/Percussion\n Tuesday, July 1, 2025   Page 3 / 5", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1323, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}}}